Pallas Capital Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.2K Buy
15,336
+1,104
+8% +$1.24K ﹤0.01% 847
2025
Q1
$11.2K Buy
+14,232
New +$11.2K ﹤0.01% 760